Clinical potential of naloxegol in the management of opioid-induced bowel dysfunction

Opioid-induced bowel dysfunction (OIBD) is a burdensome condition which limits the therapeutic benefit of analgesia. It affects the entire gastrointestinal tract, predominantly by activating opioid receptors in the enteric nervous system, resulting in a wide range of symptoms, such as reflux, bloati...

Descripción completa

Detalles Bibliográficos
Autores principales: Poulsen, Jakob Lykke, Brock, Christina, Olesen, Anne Estrup, Nilsson, Matias, Drewes, Asbjørn Mohr
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2014
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4179399/
https://www.ncbi.nlm.nih.gov/pubmed/25278772
http://dx.doi.org/10.2147/CEG.S52097

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4179399/
https://www.ncbi.nlm.nih.gov/pubmed/25278772
http://dx.doi.org/10.2147/CEG.S52097

Ejemplares similares